<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20120215009014N608</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-05-14</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effect of a course of aerobic training versus control group on blood factors and psychological symptoms in patients undergoing hemodialysis</public_title>
      <acronym></acronym>
      <scientific_title>Effect of a course of aerobic training versus control group on blood factors and psychological symptoms in patients undergoing hemodialysis: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/90070</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random allocation of patients to intervention and control groups by lottery. For this purpose, we prepare two sheets, write "intervention" on one and "control" on the other. Then, with each patient's visit, one of the sheets is randomly taken and the patient is assigned to the intervention or control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hemodialysis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Treatment and routine care for hemodialysis patients, along with aerobic exercises including pedaling on a stationary mini electric bike for 30 minutes, and resistance exercises including leg raises (two sets of 10 repetitions), heel raises (three sets of 15 repetitions), and knee flexion and extension (two sets of 10 repetitions), performed three days per week for three months. Intervention 2: Control group: Treatment and routine care for hemodialysis patients.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is It depends on the situation and the results of the study as well as the approval of the financial supporting organization.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fahimeh Ghodrati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Borujerd Branch, Navab Square,</address>
        <city>Boroujerd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6915136111</zip>
        <telephone>+98 66 4251 8000</telephone>
        <email>fahimeghoratii@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mehdi Roozbahani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, Borujerd Branch, Navab Square,</address>
        <city>Boroujerd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6915136111</zip>
        <telephone>+98 66 4251 8000</telephone>
        <email>mehdi.roozbahani@iau.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of 18 to 65 years,
Patients undergoing hemodialysis,</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Movement disorders</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z49.31</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Encounter for adequacy testing for hemodialysis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Treatment and routine care for hemodialysis patients, along with aerobic exercises including pedaling on a stationary mini electric bike for 30 minutes, and resistance exercises including leg raises (two sets of 10 repetitions), heel raises (three sets of 15 repetitions), and knee flexion and extension (two sets of 10 repetitions), performed three days per week for three months.</i_keyword>
      <i_keyword>Control group: Treatment and routine care for hemodialysis patients</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood calcium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood phosphorus level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood sodium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood potassium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood hemoglobin level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood hematocrit level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood platelet level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood creatinine level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood urea level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood albumin level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood triglyceride level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood cholesterol level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood alkaline phosphatase level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood SGOT level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood SGPT level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Blood parathyroid hormone level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.</prim_outcome>
      <prim_outcome>Psychological symptoms. Timepoint: Before the intervention and three months later. Method of measurement: Using the Garnefski standard questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-22</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University – Boroujerd Branch</contact_name>
        <contact_address>Islamic Azad University, Borujerd Branch, Navab Square Boroujerd Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
